文献速递癫痫认知障碍与痴呆

阿尔茨海默病中的癫痫活动:新见解与治疗意义

Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implications.
PubMed 文献 · Lancet Neurol · 2026-01-22

约60%的阿尔茨海默病患者在病程中出现癫痫或亚临床癫痫样活动,认知健康成人新发癫痫也增加痴呆风险。癫痫活动可加速阿尔茨海默病起病和认知下降,需高度临床警惕和神经生理监测,抗癫痫药物能否改善认知尚在研究中,抗淀粉样蛋白单抗治疗时癫痫管理尤为重要。

要点

  • 约60%阿尔茨海默病患者出现癫痫或亚临床癫痫样活动。
  • 癫痫活动是可改变的危险因素,可加速认知下降。
  • 接受抗淀粉样蛋白单抗治疗者需特别关注癫痫风险。

核心结论

  • 癫痫活动是阿尔茨海默病中可改变的危险因素,支持存在癫痫亚型,需早期识别和靶向治疗。

研究设计与样本

  • 综述性文章,检索范围未在摘要中报告。

主要发现

  • 约60%的阿尔茨海默病患者在病程中出现癫痫或亚临床癫痫样活动。
  • 认知健康成人新发癫痫增加痴呆风险。
  • 癫痫活动可加速阿尔茨海默病起病和认知下降。
  • 抗癫痫药物能否改善认知结局正在研究中。

关键数值与推荐

  • 约60%的阿尔茨海默病患者出现癫痫或亚临床癫痫样活动。

临床怎么用

  • 对阿尔茨海默病患者保持高度临床警惕并进行神经生理监测以检测癫痫活动。
  • 迟发性癫痫或阿尔茨海默病相关癫痫活动的评估和治疗应参考临床进展。
  • 接受抗淀粉样蛋白单抗治疗的患者需特别重视癫痫管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also increase the risk of developing dementia. Epileptic activity, including both seizures and subclinical epileptiform discharges, can hasten the onset of Alzheimer's disease and accelerate cognitive decline. Studies are investigating whether antiseizure medications could improve cognitive outcomes, particularly in patients with Alzheimer's disease with epileptic activity. Detection of epileptic activity in people with Alzheimer's disease requires high clinical vigilance and neurophysiological monitoring. Evaluation and treatment of late-onset epilepsy or Alzheimer's disease-associated epileptic activity should be informed by clinical advances. Epilepsy management is especially important in patients receiving anti-amyloid monoclonal antibodies, which can increase seizure risk. Recent insights support the concept of an epileptic subtype of Alzheimer's disease, position epileptic activity as a modifiable risk factor in Alzheimer's disease, highlight innovations for earlier identification of epileptic activity, and provide evidence supporting the need for early detection and targeted treatment across the stages of Alzheimer's disease.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Vossel K, Johnson EL, Cretin B, et al. Epileptic activity in Alzheimer's disease: emerging insights and therapeutic implications. Lancet Neurol. 2026. PMID: 41581519. doi:10.1016/S1474-4422(25)00425-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。